SureTrader Nadex Advertisement
Home > Boards > US Listed > Biotechs >

Eagle Pharmaceuticals, inc. (EGRX)

EGRX RSS Feed
Add EGRX Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 1/12/2017 7:38:01 PM - Followers: 24 - Board type: Free - Posts Today: 0
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
EGRX
Current Price
Volume:
Bid Ask Day's Range
SureTrader
EGRX News: Amended Statement of Ownership (sc 13g/a) 02/21/2017 04:41:31 PM
EGRX News: Eagle Pharmaceuticals Announces New Patents Issued for Bendeka 02/21/2017 09:34:00 AM
EGRX News: Eagle Pharmaceuticals, Inc. to Discuss Fourth Quarter and Full Year 2016 Financial Results on March 1, 2017 02/16/2017 07:00:00 AM
EGRX News: Amended Statement of Ownership (sc 13g/a) 02/14/2017 04:18:14 PM
EGRX News: Amended Statement of Ownership (sc 13g/a) 02/14/2017 10:27:37 AM
PostSubject
#567   EGRX Financial Update as of 12/31/16 from JP Bickema 01/12/17 07:38:01 PM
#566   Eli Lilly's Alimta escapes early generics—and a sales Bickema 01/12/17 07:07:18 PM
#565   This was the first 2017 guidance for Bendeka/Treanda, DewDiligence 01/09/17 09:47:24 AM
#564   But why did TEVA lower their sales guidance? jsmith77 01/09/17 09:23:26 AM
#563   Low 2017 sales guidance for Bendeks/Treanda. DewDiligence 01/09/17 09:21:02 AM
#562   What was the reasoning for the drop? jsmith77 01/09/17 09:19:59 AM
#561   EGRX -7% on TEVA’s 2017 guidance: #msg-127680719. DewDiligence 01/06/17 01:56:00 PM
#560   [OT]—MNTA's first NVS partnership deal (for generic Lovenox) DewDiligence 12/19/16 04:39:51 PM
#559   Dew are you aware that MNTA's former CEO Bickema 12/19/16 04:15:37 PM
#558   Something to note here is that Eagle's largest Bickema 12/18/16 11:50:45 AM
#557   Instead of me trying to articulate why this stugwins 11/17/16 03:49:08 PM
#556   msg was duplicated. Wouldn't let me delete this one. bio_fan 11/17/16 08:33:15 AM
#555   "Who knows what Biogen and the other companies bio_fan 11/17/16 08:30:38 AM
#554   Ryanodex is looking like its going to bring jsmith77 11/15/16 10:08:41 AM
#553   That's the problem with intellectual lightweights (Tarriff is stugwins 11/13/16 02:57:49 PM
#552   I guess Biogen and 11 other companies that bio_fan 11/12/16 09:40:38 PM
#551   Agreed (eom). DewDiligence 11/11/16 11:15:27 AM
#550   Dew, I fully understand your disappointment. stugwins 11/11/16 11:13:40 AM
#549   I cashed out today (#msg-126485051), so I'm resigning DewDiligence 11/11/16 10:22:49 AM
#548   I wasn't expecting this move (see bottom of DewDiligence 11/11/16 10:00:49 AM
#547   Eagle Pharmaceuticals Initiates Rolling Submission of NDA for Bickema 11/11/16 09:41:55 AM
#546   Eagle Pharmaceuticals Signs Definitive Agreement to Acquire Arsia Bickema 11/11/16 09:40:24 AM
#545   Very nice! DewDiligence 11/09/16 04:48:37 PM
#544   In regards to milestone, the answer is yes Bickema 11/09/16 04:31:57 PM
#543   Eagle Pharmaceuticals, Inc. Reports Third Quarter 2016 Results Bickema 11/09/16 08:36:55 AM
#542   The Bendeka "take-back" rights apply only when there DewDiligence 11/03/16 01:49:51 PM
#541   Mizuho increases PT to 78. bio_fan 11/03/16 01:35:39 PM
#540   Very unclear, however the market reaction is impressive Bickema 11/02/16 10:16:13 AM
#539   Unclear, but I would think the PR would DewDiligence 11/02/16 09:56:17 AM
#538   There's apparently no milestone payment for the (delayed) DewDiligence 11/02/16 09:52:13 AM
#537   Looking back at the agreement with teva. bio_fan 11/02/16 09:47:22 AM
#536   Unique J-code for Bendeka bio_fan 11/02/16 09:02:04 AM
#535   Upcoming Events Bickema 11/01/16 11:10:28 AM
#534   If I'm not mistaking a J Code would Bickema 10/31/16 12:07:50 PM
#533   Dew, thank you. GD 10/31/16 12:06:46 PM
#532   A J-code for Bendeka would allow Medicare to DewDiligence 10/31/16 07:47:03 AM
#531   EGRX reports Ryanodex preclinical data in Ecstasy-induced hyperthermia: #msg-126 DewDiligence 10/31/16 07:44:53 AM
#530   I am new here, how does a J-code GD 10/21/16 12:16:41 PM
#529   LLY will undoubtedly sue under Hatch-Waxman in order DewDiligence 10/14/16 11:47:52 AM
#528   Suing Eagle in court for patent infringement once Bickema 10/14/16 11:43:23 AM
#527   What do you mean by: "exhausting all legal options"? DewDiligence 10/14/16 11:37:40 AM
#526   Dew do you see any reason / scenario Bickema 10/14/16 11:22:56 AM
#525   I'm sure EGRX and TEVA are discussing a stugwins 10/04/16 11:37:28 AM
#524   Good point which could point to Eagle playing Bickema 09/29/16 04:39:23 PM
#523   The counter-argument is that Teva could have acquired DewDiligence 09/29/16 04:20:34 PM
#522   Ramblings on Why TEVA should acquire EGRX Bickema 09/29/16 04:18:28 PM
#521   Hopefully we learn more about these two items Bickema 09/27/16 05:32:59 PM
#520   EGRX Investor Day webcast 11/11/16: DewDiligence 09/27/16 04:41:55 PM
#519   Notes From Management Meetings - RBC Bickema 09/21/16 09:41:17 AM
#518   So am I confusing averages with highs? Bickema 09/13/16 10:33:38 AM
PostSubject